Antipsychotic therapy of schizophrenia is a trigger of lipid metabolism disorders
The relevance of this problem is due to the significant increase in the prevalence of mental disorders, particularly schizophrenia, which represents one of the most complex issues in modern medicine. According to the World Health Organization (WHO), approximately 20 million people worldwide suffer from schizophrenia, and the socioeconomic costs of treating and rehabilitating patients continue to increase. Antipsychotic therapy remains the primary treatment for this category of patients; however, its use is accompanied by a number of serious side effects, among which metabolic disturbances occupy a prominent place. In this review article, the authors analyze the results of antipsychotic use by various researchers. The paper analyzes current scientific literature on the problem under study to establish the relationship between the efficacy of antipsychotic drugs and the occurrence of metabolic disturbances during their use, including long-term use. The authors conclude that it is necessary to determine lipid metabolism indicators during the use of drugs in this category.
Authors
- Aleksey E. Kim (ORCID: https://orcid.org/0000-0003-4591-2997)
- Д.С. Богдашов (ORCID: https://orcid.org/0009-0001-6844-1588)
- Н.Н. Максимюк (ORCID: https://orcid.org/0000-0001-6634-7638)
Institutions
- S. M. Kirov Military Medical Academy (RU)
- Yaroslav-the-Wise Novgorod State University (RU)
Publication Details
- Journal
- Вестник Новгородского государственного университета им. Ярослава Мудрого
- Published
- 2026-11-19
- DOI
- https://doi.org/10.34680/2076-8052.2026.2(144).215-223
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00